Wyeth Effexor XR Gains Panic Disorder Indication
This article was originally published in The Pink Sheet Daily
Executive Summary
Extended-release venlafaxine receives the first panic disorder indication approved for an antidepressant since 2002, the firm says.
You may also be interested in...
Effexor Sales Not Significantly Impacted By Cymbalta Launch, Wyeth Says
Lilly’s SNRI is capturing share from SSRIs rather than Wyeth’s SNRI, firm says.
Effexor Sales Not Significantly Impacted By Cymbalta Launch, Wyeth Says
Lilly’s SNRI is capturing share from SSRIs rather than Wyeth’s SNRI, firm says.
Effexor XR To Go Generic In 2010 Under Settlement Between Teva and Wyeth
The deal could give Wyeth more breathing room to launch its follow-on antidepressant.